Low-grade systemic inflammation (hsCRP 2–10 mg/L) stratified risk beyond comorbidities and medications in both CKD+ASCVD and ...
Decisionmakers and policymakers – federal, state, local, private sector – need more and better information to consider and implement changes that can alter the trajectory of health care spending.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results